FA
GILD icon

Fountainhead AM’s Gilead Sciences GILD Stock Holding History

Fountainhead AM’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.9K Buy
102
+38
+59% +$5.01K 0.01% 185
2026
Q1 		$8.92K Buy
+64
New +$8.96K 0.01% 190
2025
Q4 		– Sell
-4,504
Closed -$500K – 194
2025
Q3 		$500K Sell
4,504
-15
-0.3% -$1.71K 0.07% 119
2025
Q2 		$501K Buy
4,519
+118
+3% +$12.6K 0.07% 114
2025
Q1 		$493K Buy
+4,401
New +$454K 0.08% 92

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fountainhead AM's GILD Position: Q2 2026 in Review

Fountainhead AM increased its Gilead Sciences (GILD) stake by 59% in Q2 2026, buying an estimated $5.01K and bringing the position to 102 shares worth $12.9K. The position accounts for 0.01% of the portfolio, ranked #185.

Fountainhead AM first reported a position in GILD in Q1 2025 and has held it in 5 quarters since. The position peaked at $501K in Q2 2025. 2,274 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Fountainhead AM held 102 shares of Gilead Sciences worth $12.9K as of Q2 2026.
  • Fountainhead AM bought 38 Gilead Sciences shares in Q2 2026, an estimated $5.01K.
  • Gilead Sciences made up 0.01% of Fountainhead AM's portfolio in Q2 2026, its #185 holding.
  • Fountainhead AM first reported a position in Gilead Sciences in Q1 2025 and has held it in 5 quarters since.
  • Fountainhead AM's Gilead Sciences position peaked at $501K in Q2 2025.
  • 2,274 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Fountainhead AM's 13F filing for Q2 2026, filed 3 Aug 2026.